Implementation of
Abbreviated Breast MRI Protocols

Thursday, March 10, 2016
7:00pm Eastern | 6:00pm Central | 5:00pm Mountain | 4:00pm Pacific
 

CLICK HERE TO JOIN TONIGHT'S WEBINAR

Target Audience
A certified one-hour live webinar for breast imaging physicians and radiologic technologists
 

Course Overview
Breast MRI (BMRI) has long been known for its high sensitivity and specificity for detecting breast cancer, but the full BMRI protocol is time-consuming and expensive, limiting its use to high-risk and second-look imaging. The development of abbreviated BMRI protocols is proving to be as effective as the standard protocol but requires much less scan and interpretation time, potentially making BMRI available to a broader patient population.

This lecture includes a discussion on patient indications, the abbreviated protocols now under development, and tips on how to manage patients and workflow in clinical practice.

Educational Objectives
At the conclusion of this activity, participants should be better able to:

• Discuss the published clinical studies reporting the benefits of using an abbreviated breast MRI protocol

• Implement abbreviated MRI protocols to shorten image acquisition and interpretation

• Compare the quality of clinical case images using abbreviated BMRI protocols vs current standard protocols

ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Physicians

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The European Accreditation Council for CME (EACCME®)

The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live event and e-learning materials. For more information, go to www.uems.eu.

Radiologic Technologists

This program has been approved by the American Society of Radiologic Technologists (ASRT) for 1.0 hour of ARRT Category A continuing education credit.

How to Participate
This program is offered by ICPME through WebEx webinar service.

• Click ENROLL NOW and follow the registration instructions to register with ICPME.

• You will receive an email from ICPME confirming your registration.

• At the end of the registration process, click on ACCESS WEBINAR to complete the pre-course survey as well as to register on the ICPME WebEx site.

• Detailed log-in instructions will be sent to you via e-mail the day before the webinar.

How to Receive Credit
There is no fee to participate in this activity. Each participant will need a computer with internet access. Credit cannot be granted for group viewing.

• To receive credit, each participant must register, complete the precourse survey, attend the entire session, and complete the postcourse evaluation.

• Upon verification of your participation from the WebEx event report, you will receive an email from ICPME with instructions to print your certificate from your online account within two weeks after the webinar. You will not be able to print your certificate until that time.

Faculty
Gillian M. Newstead, MD, FACR

Dr. Newstead received her medical degree from the University of Edinburgh in Scotland and completed an internship at The Genesee Hospital in Rochester, New York. Residency was completed in radiology at Strong Memorial Hospital in Rochester and Temple University Hospital in Philadelphia. She is board certified in Radiology by the American College of Radiology.

Dr. Newstead is a member of numerous medical organizations including the American College of Radiology, the Radiological Society of North America, Association for Breast Cancer Control, and the Society for Breast Imaging. She has published more than 50 papers in journals including Radiology, American Journal of Roentgenology, and European Radiology. Dr. Newstead’s awards and honors include election to fellowship status by the American College of Radiology. She was voted as the “Attending of the Year” for excellence in teaching by the residents at the New York University Department of Radiology.

Dr. Newstead’s research interests lie in breast cancer screening and diagnosis and breast MRI. Her work has been supported by grants from the American Cancer Society and the National Cancer Institute.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

The faculty has reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Gillian M. Newstead, MD, FACR has received consulting fees from Bayer AG and Bracco Diagnostics; fees for non-CME/CE services from Bayer AG; and has ownership interest in Three Palm Software.

The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Trace Hutchison, PharmD                                   Victoria Phoenix, BS
Linda McLean, MS                                             Jan Schultz, RN, MSN, CCMEP
Samantha Mattiucci, PharmD, CCMEP              Judi Smelker-Mitchek, RN, BSN

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Questions?
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
Phone: 607-257-5860 x10

Jointly Provided by

This activity is supported by an independent educational grant from Bayer Healthcare Pharmaceuticals.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.